BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21973025)

  • 1. Efficient cellular delivery of β-galactosidase mediated by NrTPs, a new family of cell-penetrating peptides.
    Rodrigues M; de la Torre BG; Rádis-Baptista G; Santos NC; Andreu D
    Bioconjug Chem; 2011 Nov; 22(11):2339-44. PubMed ID: 21973025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic uptake profiles of cell penetrating peptides in lymphocytes and monocytes.
    Rodrigues M; de la Torre BG; Andreu D; Santos NC
    Biochim Biophys Acta; 2013 Oct; 1830(10):4554-63. PubMed ID: 23707662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake and cellular distribution of nucleolar targeting peptides (NrTPs) in different cell types.
    Rodrigues M; Andreu D; Santos NC
    Biopolymers; 2015 Mar; 104(2):101-9. PubMed ID: 25620660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convergent synthesis and cellular uptake of multivalent cell penetrating peptides derived from Tat, Antp, pVEC, TP10 and SAP.
    Eggimann GA; Buschor S; Darbre T; Reymond JL
    Org Biomol Chem; 2013 Oct; 11(39):6717-33. PubMed ID: 23933745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery.
    Guterstam P; Andaloussi SE; Langel U
    Methods Mol Biol; 2011; 683():219-30. PubMed ID: 21053133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced cellular delivery of cell-penetrating peptide-peptide nucleic acid conjugates by photochemical internalization.
    Shiraishi T; Nielsen PE
    Methods Mol Biol; 2011; 683():391-7. PubMed ID: 21053145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
    Shiraishi T; Nielsen PE
    Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells.
    Nakase I; Tanaka G; Futaki S
    Mol Biosyst; 2013 May; 9(5):855-61. PubMed ID: 23306408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the uptake mechanism of NrTP, a cell-penetrating peptide preferentially targeting the nucleolus of tumour cells.
    Rádis-Baptista G; de la Torre BG; Andreu D
    Chem Biol Drug Des; 2012 Jun; 79(6):907-15. PubMed ID: 22405142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptides.
    Hassane FS; Abes R; El Andaloussi S; Lehto T; Sillard R; Langel U; Lebleu B
    J Control Release; 2011 Jul; 153(2):163-72. PubMed ID: 21536086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes.
    Jha D; Mishra R; Gottschalk S; Wiesmüller KH; Ugurbil K; Maier ME; Engelmann J
    Bioconjug Chem; 2011 Mar; 22(3):319-28. PubMed ID: 21319732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugation of cell-penetrating peptides leads to identification of anti-HIV peptides from matrix proteins.
    Narumi T; Komoriya M; Hashimoto C; Wu H; Nomura W; Suzuki S; Tanaka T; Chiba J; Yamamoto N; Murakami T; Tamamura H
    Bioorg Med Chem; 2012 Feb; 20(4):1468-74. PubMed ID: 22277590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classes and prediction of cell-penetrating peptides.
    Lindgren M; Langel U
    Methods Mol Biol; 2011; 683():3-19. PubMed ID: 21053118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of PepFect peptides for the delivery of splice-correcting oligonucleotides.
    Andaloussi SE; Lehto T; Lundin P; Langel U
    Methods Mol Biol; 2011; 683():361-73. PubMed ID: 21053143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transduction of proteins into leishmania tarentolae by formation of non-covalent complexes with cell-penetrating peptides.
    Keller AA; Breitling R; Hemmerich P; Kappe K; Braun M; Wittig B; Schaefer B; Lorkowski S; Reissmann S
    J Cell Biochem; 2014 Feb; 115(2):243-52. PubMed ID: 24038170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-penetrating peptides-based strategies for the delivery of splice redirecting antisense oligonucleotides.
    El Andaloussi S; Said Hassane F; Boisguerin P; Sillard R; Langel U; Lebleu B
    Methods Mol Biol; 2011; 764():75-89. PubMed ID: 21748634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
    Crombez L; Morris MC; Heitz F; Divita G
    Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake kinetics of cell-penetrating peptides.
    Florén A; Mäger I; Langel U
    Methods Mol Biol; 2011; 683():117-28. PubMed ID: 21053126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptophan within basic peptide sequences triggers glycosaminoglycan-dependent endocytosis.
    Bechara C; Pallerla M; Zaltsman Y; Burlina F; Alves ID; Lequin O; Sagan S
    FASEB J; 2013 Feb; 27(2):738-49. PubMed ID: 23070606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-penetrating peptides: 20 years later, where do we stand?
    Bechara C; Sagan S
    FEBS Lett; 2013 Jun; 587(12):1693-702. PubMed ID: 23669356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.